Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Very Strong
Momentum
Price
Weak
Earnings
Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.8.6555.2945
Address
Unit D2 661 Newcastle Street Leederville, Western Australia (WA) 6007
Description
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the business of researching and developing dermatology and antimicrobial products. It operates under the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in Leederville, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.12 - 0.41
Trade Value (12mth)
AU$270,884.00
1 week
1.35%
1 month
8.7%
YTD
97.37%
1 year
177.78%
All time high
163.33
EPS 3 yr Growth
-55.900%
EBITDA Margin
%
Operating Cashflow
-$12m
Free Cash Flow Return
-77.60%
ROIC
-58.90%
Interest Coverage
-155.20
Quick Ratio
5.70
Shares on Issue (Fully Dilluted)
1439m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
18 July 24 |
Issue of Securities
×
Issue of Securities |
18 July 24 |
Notification regarding unquoted securities - BOT
×
Notification regarding unquoted securities - BOT |
18 July 24 |
Notification of cessation of securities - BOT
×
Notification of cessation of securities - BOT |
17 July 24 |
Change in substantial holding from IFL
×
Change in substantial holding from IFL |
28 June 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
28 June 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
28 June 24 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
21 June 24 |
Botanix $70 Million Institutional Capital Raising
×
Botanix $70 Million Institutional Capital Raising |
21 June 24 |
Proposed issue of securities - BOT
×
Proposed issue of securities - BOT |
20 June 24 |
FDA Approves Sofdra
×
FDA Approves Sofdra |
19 June 24 |
Trading Halt
×
Trading Halt |
14 June 24 |
Change of Registered Office
×
Change of Registered Office |
12 June 24 |
Final Sofdra Labelling Discussions with FDA
×
Final Sofdra Labelling Discussions with FDA |
05 June 24 |
Change of Auditor
×
Change of Auditor |
08 May 24 |
Botanix Commercial Day Webinar Presentation
×
Botanix Commercial Day Webinar Presentation |
07 May 24 |
Botanix Webinar - Registration Information
×
Botanix Webinar - Registration Information |
30 April 24 |
March 2024 Quarterly Activities Report and Appendix 4C
×
March 2024 Quarterly Activities Report and Appendix 4C |
15 April 24 |
Botanix Included in the All Ordinaries Index
×
Botanix Included in the All Ordinaries Index |
26 March 24 |
Botanix Appoints Graeme Morissey CFO
×
Botanix Appoints Graeme Morissey CFO |
19 March 24 |
Notification of cessation of securities - BOT
×
Notification of cessation of securities - BOT |
13 March 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
13 March 24 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
11 March 24 |
Botanix to Present at Euroz Hartleys Conference
×
Botanix to Present at Euroz Hartleys Conference |
11 March 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
11 March 24 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.